Inhibitory Immunoglobulin-Like Receptors LILRB and PIR-B Negatively Regulate Osteoclast Development-Reference-Cited by-同舟云学术

Inhibitory Immunoglobulin-Like Receptors LILRB and PIR-B Negatively Regulate Osteoclast Development

Published:2008-09-18 Issue:7 Volume:181 Page:4742-4751
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Mori Yu,Tsuji Sukenao,Inui Masanori,Sakamoto Yuzuru,Endo Shota,Ito Yumi,Fujimura Shion,Koga Takako,Nakamura Akira,Takayanagi Hiroshi,Itoi Eiji,Takai Toshiyuki

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference46 articles.

1. Bone Resorption by Osteoclasts

2. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

3. Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells.

4. Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LILRB4 on multiple myeloma cells promotes bone lesion by p-SHP2/NF-κB/RELT signal pathway;Journal of Experimental & Clinical Cancer Research;2024-07-01

2. MHC1/LILRB1 axis as an innate immune checkpoint for cancer therapy;Frontiers in Immunology;2024-06-07

3. NOT gated T cells that selectively target EGFR and other widely expressed tumor antigens;iScience;2024-06

4. Differential Gene Expression Involved in Bone Turnover of Mice Expressing Constitutively Active TGFβ Receptor Type I;International Journal of Molecular Sciences;2024-05-27

5. Therapeutic and immunomodulatory potentials of mesenchymal stromal/stem cells and immune checkpoints related molecules;Biomarker Research;2024-03-21